Top news from MedWatch this week
![Photo: MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12791283.ece/ALTERNATES/schema-16_9/doc7eok1wt4jdl13ye5emaw.jpg)
Monday
Former Ambu employee fined for ”negligent insider trading”
Second half of Zealand Pharma’s congenital hyperinsulinism study data revealed at conference
New Boehringer Ingelheim general manager in Denmark wants to draw on experiences from China
Tuesday
Lundbeck ties bank loans to sustainability targets
Bavarian Nordic wins decade-long contract with Canada
Analyst predicts more monkeypox orders as Bavarian Nordic enjoys trading surge
Wednesday
FDA warns of insulin pump hacking risk
Thursday
Novo Nordisk expects phase III data for diabetes app imminently
Novo Nordisk hopes to begin approval process of once-weekly insulin in H1 2023
Clock is ticking on post-Brexit UK medical equipment laws
Friday
Eli Lilly’s Mounjaro could become one of the world’s biggest drugs ever
Coloplast lacks overview of suppliers’ gas dependence